Nocebo effect and biosimilars in inflammatory bowel diseases: what’s new and what’s next?
- DOI
- 10.1080/14712598.2020.1817374
- Published
- 2020-09-06
- Container
- Expert Opinion on Biological Therapy
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1080/14712598.2020.1817374,
title = {Nocebo effect and biosimilars in inflammatory bowel diseases: what’s new and what’s next?},
author = {Ferdinando D’Amico and Virginia Solitano and Laurent Peyrin-Biroulet and Silvio Danese},
year = {2020},
journal = {Expert Opinion on Biological Therapy},
doi = {10.1080/14712598.2020.1817374},
url = {https://doi.org/10.1080/14712598.2020.1817374}
}RIS
TY - JOUR TI - Nocebo effect and biosimilars in inflammatory bowel diseases: what’s new and what’s next? AU - Ferdinando D’Amico AU - Virginia Solitano AU - Laurent Peyrin-Biroulet AU - Silvio Danese PY - 2020 JO - Expert Opinion on Biological Therapy DO - 10.1080/14712598.2020.1817374 UR - https://doi.org/10.1080/14712598.2020.1817374 ER -
APA
D’Amico, F., Solitano, V., Peyrin-Biroulet, L., & Danese, S. (2020). Nocebo effect and biosimilars in inflammatory bowel diseases: what’s new and what’s next?. Expert Opinion on Biological Therapy. https://doi.org/10.1080/14712598.2020.1817374
Source records
- crossref · retrieved 2026-11-08T17:16:22.030Z